Eterna Therapeutics
ERNA
#10048
Rank
$13.34 M
Marketcap
$0.26
Share price
1.88%
Change (1 day)
-88.40%
Change (1 year)

P/S ratio for Eterna Therapeutics (ERNA)

P/S ratio as of March 2025 (TTM): 22.9

According to Eterna Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.3022. At the end of 2024 the company had a P/S ratio of 10.4.

P/S ratio history for Eterna Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202410.4-92.71%
2023143
2022N/A
2021N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
1.26-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
36.2 58.03%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
3.03-86.81%๐Ÿ‡ซ๐Ÿ‡ท France
8.09-64.72%๐Ÿ‡บ๐Ÿ‡ธ USA
0.2168-99.05%๐Ÿ‡ฆ๐Ÿ‡บ Australia
1.15-95.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel